Aster DM Healthcare informs about disclosure

15 Nov 2023 Evaluate

Aster DM Healthcare has informed about receipt of a confidential complaint relating to Wahat Al Aman Home Healthcare LLC (‘Wahat’), an overseas subsidiary of the Company, a forensic investigation is to be initiated by the Company. The complaint alleges that certain employees of Wahat have engaged in forgery and fraud resulting in irregularities in revenue recognition by Wahat and trade receivable balances. The Company has recognised a full provision against the trade receivables balance of INR 54.62 Crores since it is in the process of compiling and evaluating evidence to establish recoverability of these receivables. On completion of the investigations, the Company will reassess if any further adjustments and disclosures are required. The Company and/ or Wahat will take appropriate legal actions in respect of the relevant employees and relevant third parties in respect of the matters underlying the complaint, based on the outcome of the investigation. Details as required under LODR Regulations read with SEBI Circular No. SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated July 13, 2023 (‘SEBI Circular’) are annexed.

The above information is a part of company’s filings submitted to BSE.

Aster DM Healthcare Share Price

555.35 -20.65 (-3.59%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6801.30
Max Healthcare Inst 991.50
Narayana Hrudayalay 1749.05
Aster DM Healthcare 555.35
Global Health 1029.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×